Drug General Information
Drug ID	D08OUL
Former ID	DNCL002849
Drug Name	EGT-0001474
Indication	Type 2 diabetes [ICD9: 250; ICD10:E11]		Phase 1	[522600]
Company	Theracos
Structure		Download 2D MOL
Target and Pathway
Target(s)	SLGT2	Target Info	Modulator
Reactome	Hexose transport
	Na+-dependent glucose transporters
	Inositol transporters
WikiPathways	NRF2 pathway
	Nuclear Receptors Meta-Pathway
	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
References
Ref 522600	ClinicalTrials.gov (NCT00854113) Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.